Lexicon’s Sunny Take Does Not Sway Investors About Phase IIb DPNP Miss

 
• By Joseph Haas
  
Lexicon hopes to move into Phase III in diabetic peripheral neuropathic pain despite mixed Phase IIb data

More from Clinical Trials

More from Therapy Areas